Clinical response to induction chemotherapy predicts local control and long-term survival in multimodal treatment of patients with locally advanced esophageal cancer

Journal of Cancer Research and Clinical Oncology

Volumn 131, Issue 1, 2005, Pages 67-72

  Stahl, Michael ^a   Wilke, Hansjochen ^a   Stuschke, Martin ^b   Walz, Martin K ^a   Fink, Ulrich ^c   Molls, Michael ^c   Siewert, J Rüdiger ^c   Schroeder, Michael ^d   Makoski, Hans Bruno ^e   Schmidt, Ulrich ^b   Seeber, Siegfried ^b   Vanhoefer, Udo ^b  

^a KLINIKEN ESSEN MITTE   (Germany)

^b UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d ST JOHANNES HOSPITAL   (Germany)

^e Klinikum Duisburg   (Germany)

Author keywords

Locally advanced esophageal cancer; Multivariate analysis; Neoadjuvant radiochemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID;

ADULT; AGED; ARTICLE; CANCER CONTROL; CHEMOTHERAPY; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SEPSIS; SIDE EFFECT; SURVIVAL RATE; SURVIVAL TIME; TIME SERIES ANALYSIS; WEIGHT REDUCTION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; ESOPHAGUS RESECTION; PHASE 2 CLINICAL TRIAL; RADIATION DOSE; TUMOR GROWTH;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; REMISSION INDUCTION; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 19944426527     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-004-0604-5     Document Type: Article

References (20)

1. Killinger WA, Rice TW, Adelstein DJ, Medendorp SV, et al (1996) Stage II esophageal carcinoma: the significance of T and N. J Thorac Cardiovasc Surg 111:935-940
2. Siewert JR, Stein H, Feith M, et al (2001) Histologic tumor type is an independent prognostic parameter in esophageal cancer. Lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg 234:360-369
3. Urschel JD, Vasan H (2003) A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery alone for resectable esophageal cancer. Am J Surg 185:538-543
4. Stahl M, Wilke H, Fink U, Stuschke M, et al (1996) Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer: interim analysis of a phase II trial. J Clin Oncol 14:829-837
5. Hermanek P, Sobin LH, UICC (1992) TNM Classification of Malignant Tumors. 4th edn., 2nd revision. Springer, Berlin Heidelberg New York
6. Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170
7. Cox DR (1972) Regression models and life tables (with discussion). J R Stat Soc B 34:187-220
8. Sugimachi K (1998) Advances in the surgical treatment of oesophageal cancer. Br J Surg 85:298-290
9. Siewert JR, Feith M, Werner M, et al (2000) Adenocarcinoma of the esophagogastric junction. Results of surgical therapy based on an anatomical/topographic classification in 1,002 consecutive patients. Ann Surg 232:353-261
10. Geh JI, Crellin AM, Glynne-Jones R (2001) Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer. Br J Surg 88:338-356
11. Slater MS, Holland J, Faigel DO, et al (2001) Does neoadjuvant chemoradiation downstage esophageal carcinoma? Am J Surg 181:440-444
12. Peters JH, Hoeft SF, Heimbucher J, et al (1994) Selection of patients for curative or palliative resection of esophageal cancer based on preoperative endoscopic ultrasonography. Arch Surg 129:534-539
13. Alexander EP, Lipman T, Harmon J, et al (2000) Aggressive multimodality therapy for stage III esophageal cancer: a phase I/II study. Ann Thorac Surg 69:363-368
14. Adelstein DJ, Rice TW, Rybicki LA, et al (2000) Does paclitaxel improve the chemoradiotherapy of locoregionally advanced esophageal cancer? A nonrandomized comparison with fluorouracil-based therapy. J Clin Oncol 18:2032-2039
15. Ajani JA, Komaki R, Putnam JB, et al (2001) A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the oesophagus or gastroesophageal junction. Cancer 92:279-286
16. Putnam JB, Suell DM, McMurtrey MJ, et al (1994) Comparison of three techniques of oesophagectomy within a residency training program. Ann Thorac Surg 57:319-325
17. Bosset JF, Gignoux M, Triboulet JP, et al (1997) Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the oesophagus. N Engl J Med 337:161-167
18. Walsh TN, Noonan N, Hollywood D, et al (1996) A comparison of multimodal therapy and surgery for esohageal adenocarcinoma. N Engl J Med 335:462-467
19. Stahl M, Wilke H, Walz MK, et al (2003) Randomized phase III trial in locally advanced squamous cell carcinoma of the esophagus: chemoradiation with and without surgery. Proc ASCO 22:250 [abstr]
20. Bedenne L, Michel P, Bouche O, et al (2002) Randomized phase III trial in locally advanced esophageal cancer: radiochemotherapy followed by surgery versus radiochemotherapy alone (FFCD 9102). Proc ASCO 21:130 [abstr]